Sonnet Biotherapeutics (SONN) Q3 2025 Earnings

Dec 16Confirmed
Q1 2025
Q2 2025
Q3 2025
Q3 2025
-1.56
-1.2
-0.85
-0.49

Details

Expected EPS
-0.49
Actual EPS
-0.79
Surprise EPS
-0.3
Surprise Percent
-61.22%

Description

⁨Sonnet Biotherapeutics⁩ (⁦SONN⁩) has reported earnings of ⁦-0.79⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts